Loading...
AT-58 JCOG0911 INTEGRA TRIAL: A RANDOMIZED SCREENING PHASE II TRIAL OF CHEMORADIOTHERAPY WITH INTERFERONβ PLUS TEMOZOLOMIDE VERSUS CHEMORADIOTHERAPY WITH TEMOZOLOMIDE ALONE FOR NEWLY-DIAGNOSED GLIOBLASTOMA
BACKGROUND: Our lab experiments showed that interferonβ (IFNβ) markedly enhanced chemosensitivity to temozolomide (TMZ) via the down-regulation of MGMT transcription. Followed by phase I trial, INTEGRA trial investigated the efficacy of TMZ + IFNβ therapy by a randomized screening design as compared...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4217838/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.57 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|